title: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.
authors.affiliation: Center for Molecular Imaging and Experimental Radiotherapy, Université catholique de Louvain, St-Luc University Hospital, Brussels, Belgium.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Christian
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Deheneffe
authors.forename: Anne
authors.initials: A
authors.lastname: Bol
authors.forename: Marc
authors.initials: M
authors.lastname: De Bast
authors.forename: Daniel
authors.initials: D
authors.lastname: Labar
authors.forename: John A
authors.initials: JA
authors.lastname: Lee
authors.forename: Vincent
authors.initials: V
authors.lastname: Grégoire
mesh_terms: D000818:Animals; D002250:Carbon Radioisotopes; D004195:Disease Models, Animal; D057918:Fiducial Markers; D019788:Fluorodeoxyglucose F18; D000860:Hypoxia / Q000000981:diagnostic imaging*; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000000981:diagnostic imaging*; D009593:Nitroimidazoles; D011877:Radionuclide Imaging
chemical_list: C438056:2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide; D002250:Carbon Radioisotopes; D009593:Nitroimidazoles; D019788:Fluorodeoxyglucose F18